ESBL and carbapenemases in Enterobacteriaceae;Bêtalactamases à spectre étendu et carbapénémases chez les Enterobacteriaceae

Revue Medicale Suisse

Volumn 10, Issue 450, 2014, Pages 2142-2148

  Cherkaoui, A ^a   Emonet, S ^a   Renzi, G ^a   Riat, A ^a   Greub, G ^b   Schrenzel, J ^a  

^a HUG   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ARTICLE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; NONHUMAN; DRUG DESIGN; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG DESIGN; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84910624882     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kumar A, Schweizer HP. Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv Drug Deliv Rev 2005;57:1486-513
2. D'Costa VM, King CE, Kalan L, et al. Antibiotic resistance is ancient. Nature 2011;477:457-61
3. Lederman ER, Crum NF. Klebsiella liver abscess: A coast-to-coast phenomenon. Clin Infect Dis 2005;41: 273
4. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: An emerging disease with unique clinical characteristics. Am J Gastroenterol 2005;100:322-31
5. Abdul-Hamid A, Bailey SJ. Klebsiella pneumoniae liver abscess and endophthalmitis. BMJ Case Rep 2013; epub ahead of print
6. Rodriguez-Martinez JM, Poirel L, Nordmann P. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53: 1766-71
7. Hawser SP, Badal RE, Bouchillon SK, et al. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011. J Infect 2014;68:71-6
8. Canton R, Novais A, Valverde A, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(Suppl. 1):144-53
9. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13
10. Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae-a case-control study in a low prevalence country. PloS One 2013;8:e69581
11. Fankhauser C, Zingg W, Francois P, et al. Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss tertiary care hospital. Swiss Med Wkly 2009;139:747-51
12. Pasricha J, Koessler T, Harbarth S, et al. Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland. Antimicrob Resist Infect Control 2013;2:20
13. Queenan AM, Bush K. Carbapenemases: The versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-58
14. Nordmann P. Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge. Med Mal Infect 2014;44:51-6
15. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25:682-707
16. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: An environmental point prevalence study. Lancet Infect Dis 2011;11:355-62
17. Poirel L, Savov E, Nazli A, et al. Outbreak caused by NDM-1-and RmtB-producing Escherichia coli in Bulgaria. Antimicrob Agents Chemother 2014;58:2472-4
18. Brink AJ, Coetzee J, Corcoran C, et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol 2013;51:369-72
19. Nüesch-Inderbinen M, Zurfluh K, Hachler H, Stephan R. No evidence so far for the dissemination of carbapenemase-producing Enterobactericeae in the community in Switzerland. Antimicrob Resist Infect Control 2013;2:23
20. Zurfluh K, Hachler H, Nüesch-Inderbinen M, Stephan R. Characteristics of extended-spectrum beta-lactamaseand carbapenemase-producing Enterobacteriaceae isolates from rivers and lakes in Switzerland. Appl Environ Microbiol 2013;79:3021-6
21. Rodríguez-Baño J, Navarro MD, Retamar P, Picon E, Pascual A. Beta-Lactam/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: A post hoc analysis of prospective cohorts. Clin Infect Dis 2012;54:167-74
22. Retamar P, Lopez-Cerero L, Muniain MA, Pascual A, Rodriguez-Bano J. Impact of the MIC of piperacillintazobactam on the outcome of patients with bacteremia due to extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 2013;57:3402-4
23. Perez F, Bonomo RA. Can we really use ss-lactam/ss-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ss-lactamaseproducing bacteria ? Clin Infect Dis 2012;54:175-7
24. Seiffert SN, Perreten V, Johannes S, et al. OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland. Antimicrob Agents Chemother 2014;58:2446-9
25. Lemmenmeier E, Kohler P, Bruderer T, et al. First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: Infection control measures and clinical management. Infection 2014;42:529-34
26. Abbas M, Cherkaoui A, Fankhauser C, Schrenzel J, Harbarth S. Carbapénémases: implications cliniques et épidémiologiques pour la Suisse. Rev Med Suisse 2012; 8:882-9
27. Poirel L, Schrenzel J, Cherkaoui A, et al. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother 2011;66:1730-3
28. Potron A, Schrenzel J, Poirel L, et al. Emergence of OXA-48-producing Enterobacteriaceae in Switzerland. Int J Antimicrob Agents 2012;40:563-4
29. Babouee B, Widmer AF, Dubuis O, et al. Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. Euro Surveill 2011;16
30. Glasner C, Albiger B, Buist G, et al. Carbapenemase-producing Enterobacteriaceae in Europe: A survey among national experts from 39 countries, February 2013. Euro Surveill 2013;18
31. Karabinis A, Paramythiotou E, Mylona-Petropoulou D, et al. Colistin for Klebsiella pneumoniae-associated sepsis. Clin Infect Dis 2004;38:e7-9
32. Souli M, Kontopidou FV, Papadomichelakis E, et al. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek university hospital. Clin Infect Dis 2008; 46:847-54
33. Daikos GL, Petrikkos P, Psichogiou M, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009;53:1868-73
34. Maltezou HC, Giakkoupi P, Maragos A, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009;58:213-9
35. Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis 2009;64:233-5
36. Mouloudi E, Protonotariou E, Zagorianou A, et al. Bloodstream infections caused by metallo-beta-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: Risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010;31:1250-6
37. Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011;17:1798-803.